Creative Medical Technology Stock Alpha and Beta Analysis
| CELZ Stock | USD 2.02 0.09 4.27% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Creative Medical Technology. It also helps investors analyze the systematic and unsystematic risks associated with investing in Creative Medical over a specified time horizon. Remember, high Creative Medical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Creative Medical's market risk premium analysis include:
Beta 1.7 | Alpha (1.23) | Risk 5.3 | Sharpe Ratio (0.09) | Expected Return (0.50) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Creative Medical Analysis, Creative Medical Valuation, Creative Medical Correlation, Creative Medical Hype Analysis, Creative Medical Volatility, Creative Medical Price History and analyze Creative Medical Performance. Creative Medical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Creative Medical market risk premium is the additional return an investor will receive from holding Creative Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Creative Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Creative Medical's performance over market.| α | -1.23 | β | 1.70 |
Creative Medical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Creative Medical's Buy-and-hold return. Our buy-and-hold chart shows how Creative Medical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Creative Medical Market Price Analysis
Market price analysis indicators help investors to evaluate how Creative Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Creative Medical shares will generate the highest return on investment. By understating and applying Creative Medical stock market price indicators, traders can identify Creative Medical position entry and exit signals to maximize returns.
Creative Medical Return and Market Media
The median price of Creative Medical for the period between Mon, Nov 3, 2025 and Sun, Feb 1, 2026 is 2.22 with a coefficient of variation of 27.14. The daily time series for the period is distributed with a sample standard deviation of 0.68, arithmetic mean of 2.51, and mean deviation of 0.49. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Quarterly Trades Will Creative Medical Technology Holdings Inc. stock gain from government policies - Long Setup Daily Market Momentum Tracking - Fundao Cultura... | 11/06/2025 |
2 | How Creative Medical Technology Holdings Inc. stock performs in weak economy - July 2025 Movers AI Based Buy and Sell Signals - newser.com | 11/10/2025 |
3 | Is Creative Medical Technology Holdings Inc. stock cheap compared to fundamentals - Portfolio Return Summary Weekly High Return Stock Opportunities - newser.com | 11/14/2025 |
4 | Full technical analysis of Creative Medical Technology Holdings Inc. stock - Trade Volume Report Daily Oversold Stock Bounce Ideas - newser.com | 11/19/2025 |
5 | Creative Medical Technology Holdings Announces World Health Organization Approval of olastrocel as INN for Lead Allogeneic Cell Therapy CELZ-201 | 12/02/2025 |
6 | What risks investors should watch in Creative Medical Technology Holdings Inc. stock - Dollar Strength Weekly Top Stock Performers List - | 12/18/2025 |
7 | Why Creative Medical Technology Holdings Inc. stock remains a top recommendation - Market Volatility Update Trusted Financial Advisors at No Cost - bollywoodhel... | 12/23/2025 |
8 | Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 in the Treatment of Chroni... | 01/13/2026 |
9 | Sentiment Watch What is Creative Medical Technology Holdings Incs book value per share - 2025 Performance Recap Fast Moving Market Watchlists - baoquankhu1.vn | 01/16/2026 |
10 | Disposition of 2200 shares by Creative Medical Health Inc. of Creative Medical at 0.42 subject to Rule 16b-3 | 01/20/2026 |
About Creative Medical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Creative or other stocks. Alpha measures the amount that position in Creative Medical Tec has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 0.0113 | 0.0161 | 0.0185 | 0.0176 | Days Of Inventory On Hand | 668.56 | 182.0 | 163.8 | 212.78 |
Creative Medical Upcoming Company Events
As portrayed in its financial statements, the presentation of Creative Medical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Creative Medical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Creative Medical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Creative Medical. Please utilize our Beneish M Score to check the likelihood of Creative Medical's management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Creative Medical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.